CR8811A - Compuestos de opioide carboxamido - Google Patents
Compuestos de opioide carboxamidoInfo
- Publication number
- CR8811A CR8811A CR8811A CR8811A CR8811A CR 8811 A CR8811 A CR 8811A CR 8811 A CR8811 A CR 8811A CR 8811 A CR8811 A CR 8811A CR 8811 A CR8811 A CR 8811A
- Authority
- CR
- Costa Rica
- Prior art keywords
- opioid
- carboxamido compounds
- modulating
- disorder
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/38—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Esta invencion se refiere a compuestos opioides de carboxamido que son farmaceuticamente utiles como agentes para tratar o para modular un trastorno del sistema nervioso centarl y metodos para tratar o para modular un transtorno del sistema nervioso central.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57129804P | 2004-05-14 | 2004-05-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR8811A true CR8811A (es) | 2009-01-14 |
Family
ID=35064532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR8811A CR8811A (es) | 2004-05-14 | 2006-12-13 | Compuestos de opioide carboxamido |
Country Status (22)
Country | Link |
---|---|
US (2) | US7244866B2 (es) |
EP (1) | EP1748978B1 (es) |
JP (1) | JP5420170B2 (es) |
KR (1) | KR101204751B1 (es) |
CN (1) | CN1984879B (es) |
AR (1) | AR049276A1 (es) |
AU (1) | AU2005245403B2 (es) |
BR (1) | BRPI0511137A (es) |
CA (1) | CA2566601C (es) |
CR (1) | CR8811A (es) |
EA (1) | EA013261B1 (es) |
EC (1) | ECSP067008A (es) |
ES (1) | ES2485867T3 (es) |
HK (1) | HK1101246A1 (es) |
IL (1) | IL179196A (es) |
MX (1) | MXPA06013270A (es) |
NO (1) | NO20065768L (es) |
NZ (1) | NZ551288A (es) |
TW (1) | TWI418345B (es) |
UA (1) | UA90432C2 (es) |
WO (1) | WO2005113486A1 (es) |
ZA (1) | ZA200610446B (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060254029A1 (en) * | 2005-05-11 | 2006-11-16 | Conrad Swenson | Pocket loss prevention device |
AU2005245403B2 (en) * | 2004-05-14 | 2012-04-19 | Janssen Pharmaceutica N.V. | Carboxamido opioid compounds |
CN101686672A (zh) * | 2007-05-31 | 2010-03-31 | 塞普拉柯公司 | 苯基取代的环烷胺作为一元胺再摄取抑制剂 |
CA2754984C (en) * | 2009-03-19 | 2018-06-26 | Alkermes, Inc. | Morphinan derivatives with high oral bioavailability |
ME03468B (me) * | 2009-12-04 | 2020-01-20 | Alkermes Pharma Ireland Ltd | Derivati morfinana za liječenje predoziranja lijekom |
AU2011293502B2 (en) | 2010-08-23 | 2015-03-19 | Alkermes Pharma Ireland Limited | Methods for treating antipsychotic-induced weight gain |
US9029543B2 (en) | 2011-04-05 | 2015-05-12 | Alkermes, Inc. | Process for the synthesis of quaternary amine compounds |
KR101996108B1 (ko) | 2011-12-15 | 2019-10-01 | 엘커메스 파마 아일랜드 리미티드 | 부프레놀핀 및 뮤-오피오이드 수용체 길항물질의 조성물 |
US9211293B2 (en) | 2011-12-15 | 2015-12-15 | Alkermes Pharma Ireland Limited | Opioid agonist antagonist combinations |
WO2014190271A2 (en) | 2013-05-24 | 2014-11-27 | Alkermes Pharma Ireland Limted | Methods for treating depressive symptoms |
AU2014268361B2 (en) | 2013-05-24 | 2018-09-06 | Alkermes Pharma Ireland Limited | Morphan and morphinan analogues, and methods of use |
CN104940709A (zh) * | 2015-07-22 | 2015-09-30 | 张秋英 | 一种镇痛麻醉喷雾剂 |
CN105055756A (zh) * | 2015-09-18 | 2015-11-18 | 张秋英 | 一种阴部挫伤用镇痛气雾剂 |
EP3570838B1 (en) | 2017-01-17 | 2024-06-05 | Mebias Discovery, Inc. | Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using same |
EP4243768A1 (en) | 2020-11-12 | 2023-09-20 | Alkermes Pharma Ireland Limited | Immediate release multilayer tablet |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2071897A1 (en) | 1989-12-28 | 1991-06-29 | Richard A. Glennon | Sigma receptor ligands and the use thereof |
US6071970A (en) | 1993-02-08 | 2000-06-06 | Nps Pharmaceuticals, Inc. | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
DE4426245A1 (de) | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
DE60133584T2 (de) * | 2000-10-31 | 2009-06-04 | Rensselaer Polytechnic Institute | 4-arylpiperidine als opioidrezeptorbindende agenzien |
DE10059413A1 (de) * | 2000-11-30 | 2002-06-20 | Gruenenthal Gmbh | Verwendung von substituierten 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur Therapie der Harninkontinenz |
DE10146275A1 (de) * | 2001-09-18 | 2003-04-24 | Gruenenthal Gmbh | Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz |
WO2003048113A1 (en) * | 2001-11-30 | 2003-06-12 | Sepracor Inc. | Tramadol analogs and uses thereof |
DE10213051B4 (de) | 2002-03-23 | 2013-03-07 | Grünenthal GmbH | Substituierte 4-Aminocyclohexanole |
KR20050083816A (ko) * | 2002-10-25 | 2005-08-26 | 라보팜 인코포레이트 | 24시간 효능의 서방 트라마돌 조성물 |
PT2573068E (pt) | 2004-03-15 | 2015-04-27 | Janssen Pharmaceutica Nv | Processo para a preparação de intermediários de compostos úteis como moduladores do recetor opióide |
AU2005245403B2 (en) * | 2004-05-14 | 2012-04-19 | Janssen Pharmaceutica N.V. | Carboxamido opioid compounds |
-
2005
- 2005-05-11 AU AU2005245403A patent/AU2005245403B2/en not_active Ceased
- 2005-05-11 NZ NZ551288A patent/NZ551288A/en not_active IP Right Cessation
- 2005-05-11 EP EP05757373.5A patent/EP1748978B1/en active Active
- 2005-05-11 US US11/126,771 patent/US7244866B2/en active Active
- 2005-05-11 KR KR1020067026102A patent/KR101204751B1/ko active IP Right Grant
- 2005-05-11 WO PCT/US2005/016581 patent/WO2005113486A1/en active Application Filing
- 2005-05-11 ES ES05757373.5T patent/ES2485867T3/es active Active
- 2005-05-11 CN CN2005800237355A patent/CN1984879B/zh not_active Expired - Fee Related
- 2005-05-11 MX MXPA06013270A patent/MXPA06013270A/es active IP Right Grant
- 2005-05-11 BR BRPI0511137-4A patent/BRPI0511137A/pt not_active IP Right Cessation
- 2005-05-11 EA EA200602115A patent/EA013261B1/ru not_active IP Right Cessation
- 2005-05-11 JP JP2007513340A patent/JP5420170B2/ja not_active Expired - Fee Related
- 2005-05-11 CA CA2566601A patent/CA2566601C/en not_active Expired - Fee Related
- 2005-05-13 AR ARP050101970A patent/AR049276A1/es not_active Application Discontinuation
- 2005-05-13 TW TW094115467A patent/TWI418345B/zh not_active IP Right Cessation
- 2005-11-05 UA UAA200612496A patent/UA90432C2/uk unknown
-
2006
- 2006-11-12 IL IL179196A patent/IL179196A/en not_active IP Right Cessation
- 2006-11-15 EC EC2006007008A patent/ECSP067008A/es unknown
- 2006-12-13 ZA ZA200610446A patent/ZA200610446B/en unknown
- 2006-12-13 CR CR8811A patent/CR8811A/es not_active Application Discontinuation
- 2006-12-14 NO NO20065768A patent/NO20065768L/no not_active Application Discontinuation
-
2007
- 2007-08-02 HK HK07108442.0A patent/HK1101246A1/xx not_active IP Right Cessation
-
2008
- 2008-07-30 US US12/182,462 patent/US7745492B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
ECSP067008A (es) | 2006-12-29 |
EP1748978A1 (en) | 2007-02-07 |
WO2005113486A1 (en) | 2005-12-01 |
NO20065768L (no) | 2007-02-07 |
AU2005245403A1 (en) | 2005-12-01 |
US20080280990A1 (en) | 2008-11-13 |
KR101204751B1 (ko) | 2012-11-27 |
TW200605871A (en) | 2006-02-16 |
CN1984879A (zh) | 2007-06-20 |
EA013261B1 (ru) | 2010-04-30 |
US7745492B2 (en) | 2010-06-29 |
US7244866B2 (en) | 2007-07-17 |
IL179196A0 (en) | 2007-03-08 |
EP1748978B1 (en) | 2014-06-04 |
ES2485867T3 (es) | 2014-08-14 |
MXPA06013270A (es) | 2007-04-23 |
CN1984879B (zh) | 2011-07-27 |
HK1101246A1 (en) | 2007-10-12 |
TWI418345B (zh) | 2013-12-11 |
JP5420170B2 (ja) | 2014-02-19 |
EA200602115A1 (ru) | 2007-04-27 |
UA90432C2 (uk) | 2010-04-26 |
AU2005245403B2 (en) | 2012-04-19 |
ZA200610446B (en) | 2008-07-30 |
US20050256203A1 (en) | 2005-11-17 |
CA2566601C (en) | 2013-04-09 |
IL179196A (en) | 2012-10-31 |
CA2566601A1 (en) | 2005-12-01 |
JP2007537278A (ja) | 2007-12-20 |
NZ551288A (en) | 2010-10-29 |
KR20070015613A (ko) | 2007-02-05 |
AR049276A1 (es) | 2006-07-12 |
BRPI0511137A (pt) | 2007-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR8811A (es) | Compuestos de opioide carboxamido | |
CR10310A (es) | Compuestos nuevos | |
BRPI0808775A2 (pt) | compostos e composições como moduladores de atividade de gpr119 | |
CR11292A (es) | Compuestos y composiciones como moduladores de la actividad de gpr119 | |
BRPI0517015A (pt) | compostos e composições como inibidores de atividade de receptor 1 de canabinóide | |
TW200745109A (en) | Pyrrolo-pyridine kinase modulators | |
TNSN07027A1 (en) | Pyrrolo-pyridine kinase modulators | |
MX2009004047A (es) | Compuestos organicos. | |
ECSP088852A (es) | Azolopirimidinas como inhibidores de la actividad canabinoidea 1 | |
CR20130640A (es) | Métodos para tratar o prevenir trastornos relacionados con el colesterol | |
ECSP088676A (es) | Pirazolquinolonas como potentes inhibidores de parp | |
TW200942533A (en) | Pyridyl inhibitors of hedgehog signalling | |
EA201001329A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
PA8568701A1 (es) | Compuestos que modulan la actividad de ppar | |
MX2010002732A (es) | Inhibidores de f1f0-atpasa y metodos relacionados. | |
CL2011000043A1 (es) | Compuestos derivados de benzoazepina sustituidos; compuestosintermediarios; metodo de sintesis; composicion farmaceutica; y uso en el tratamiento o prevencion de un trastorno del sistema nervioso central. | |
DOP2006000051A (es) | Inhibidores de vegf-r2 y métodos | |
PA8568601A1 (es) | Compuestos que modulan la actividad de ppar | |
HN2009000018A (es) | Inhibidores de tirosina quinasa | |
EA201001332A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
IN2012DN02471A (es) | ||
UY29161A1 (es) | Nuevos heterociclos | |
HN2003000080A (es) | Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos y procedimientos para su uso | |
AR060088A1 (es) | Metodos para tratar trastornos cognitivos y otros afines | |
TW200716579A (en) | Novel chemical compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |